Skip to content

A prospective pilot study of biofeedback training with “Contrain” in patients with major Low Anterior Resection Syndrome (LARS) and faecal incontinence symptoms after anterior resection for rectal cancer

A prospective pilot study of biofeedback training with “Contrain” in patients with major LARS and faecal incontinence symptoms after anterior resection for rectal cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12623001178639
Enrollment
3
Registered
2023-11-14
Start date
2023-10-10
Completion date
2025-10-10
Last updated
2023-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study is evaluating the efficacy of delivering pelvic floor physiotherapy using biofeedback and electrical stimulation techniques to help re-train the rectal muscles and improve faecal continence. Who is it for? You may be eligible for this study if you are aged 18 to 80 years old, and have major low anterior resection syndrome (LARS) after surgery for rectal cancer. Study details Participants will choose to either receive pelvic floor biofeedback stimulation or standard care. Pelvic floor biofeedback stimulation will involve using the Contrain multifunction trainer for up to two 20-minute sessions per day for nine months. Participants will be asked to complete questionnaires on their faecal incontinence symptoms and quality of life over the course of the nine-month study period. It is hoped that results from this pilot study will help determine the feasibility of pelvic floor biofeedback stimulation after rectal cancer surgery, to help develop a larger study in the future.

Interventions

Each participant allocated to treatment will be given a training programme with the Contrain® multifunction trainer (Procon GmbH, Hamburg, Germany). Patients will undergo two 20-minute sessions per day for nine months, with encouragement to do this morning and evening. The initial session is supervised by a physiotherapist, and subsequent sessions are performed at home, with remote support from the study’s physiotherapist as required. The participant will be asked to perform exercises while stan

Each participant allocated to treatment will be given a training programme with the Contrain® multifunction trainer (Procon GmbH, Hamburg, Germany). Patients will undergo two 20-minute sessions per day for nine months, with encouragement to do this morning and evening. The initial session is supervised by a physiotherapist, and subsequent sessions are performed at home, with remote support from the study’s physiotherapist as required. The participant will be asked to perform exercises while standing, with the probe inserted into their anus or with skin pads surrounding the anus depending on patient preference. They will select the routines and intensity of the electrical stimulation. The Contrain gives immediate on-screen feedback, which includes clearly documenting the strength of the contraction of the pelvic floor and anal sphincters. Feedback on contraction strength is given in microvolts, and participants are encouraged to contract at >80% of their capacity, which is determined by maximal contractions with the device. This will assist participants to correctly perform the exercises as they can see what their values are. In certain routines the timing of the electrical stimulation can be co-ordinated with the electromyography (EMG) readings to help increase the strength of the maximal achieved muscle contraction, as well as improve neurological feedback to the brain. This is known as "triple target therapy", combining biofeedback, stimulation, and pelvic floor exercises. The number of exercises per day, and the performance in each exercise, will be recorded by the Contrain device. In addition to this, an intermittent clinical review (once every three months, for 30 minutes a session) will be performed by the study’s physiotherapist. At this time the performance in terms of frequency of exercise sessions and improvement in the strength of contraction will be reviewed. The ability of the participant to coordinate contraction, as well as relax the pelvic floor on bearing down, will also be reviewed. During the intervention, participants will not receive pelvic floor physiotherapy.

Sponsors

University of Otago
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Previous rectal cancer surgery 2. Full continuity of the gastrointestinal tract (If a stoma was formed it has subsequently been closed at least a year prior to enrolment in this study) 3. Major LARS (score > 30) 4. Previous treatment has been given for LARS, including medications such as loperamide, dietary advice and treatment for bile acid malabsorption (BAM). 5. Aged 18-80 6. Able to give informed consent 7. Participant is available to commit to up to 36 weeks of biofeedback training. 8. Participant is sufficiently motivated to commit to two training sessions a day for 6-9 months.

Exclusion criteria

Cognitive disorders impeding pelvic floor rehabilitation.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026